Targeting the autophagy pathway using ectopic expression of beclin 1 in combination with rapamycin in drug-resistant v-Ha-ras-transformed NIH 3T3 cells

Molecules and Cells

Volumn 31, Issue 3, 2011, Pages 231-238

  Eum, Ki Hwan ^a   Lee, Michael ^a  

^a SolarLight Ltd   (South Korea)

Author keywords

Autophagy; Beclin 1; Chemotherapy; MDR; Rapamycin

Indexed keywords

BECLIN 1; CYCLIN DEPENDENT KINASE INHIBITOR 1; CYCLIN DEPENDENT KINASE INHIBITOR 1B; MAMMALIAN TARGET OF RAPAMYCIN; RAPAMYCIN;

ARTICLE; AUTOPHAGOSOME; AUTOPHAGY; CANCER CELL; CANCER INHIBITION; CELL CYCLE ARREST; CELL CYCLE G1 PHASE; CELL DEATH; CELL STRAIN; CELL VIABILITY; CONTROLLED STUDY; CYTOTOXICITY; MULTIDRUG RESISTANCE; PROTEIN EXPRESSION; SIGNAL TRANSDUCTION; UPREGULATION;

ANIMALS; ANTIBIOTICS, ANTINEOPLASTIC; ANTINEOPLASTIC AGENTS, PHYTOGENIC; APOPTOSIS REGULATORY PROTEINS; AUTOPHAGY; CASPASE 3; CELL CYCLE; CELL LINE, TRANSFORMED; CELL SURVIVAL; CELL TRANSFORMATION, NEOPLASTIC; CYCLIN-DEPENDENT KINASE INHIBITOR P21; CYCLIN-DEPENDENT KINASE INHIBITOR P27; DRUG RESISTANCE, NEOPLASM; MICE; NIH 3T3 CELLS; P-GLYCOPROTEIN; PACLITAXEL; RAS PROTEINS; SIGNAL TRANSDUCTION; SIROLIMUS;

MAMMALIA;

EID: 79959937240     PISSN: 10168478     EISSN: 02191032     Source Type: Journal    
DOI: 10.1007/s10059-011-0034-6     Document Type: Article

References (33)

1. Arceci, R.J., Stieglitz, K., and Bierer, B.E. (1992). Immunosuppressants FK506 and rapamycin function as reversal agents of the multidrug resistance phenotype. Blood 80, 1528-1536.
2. Cao, Y., and Klionsky, D.J. (2007). Physiological functions of Atg6/Beclin 1: a unique autophagy-related protein. Cell Res. 17, 839-849. (Pubitemid 47585112)
3. Dancey, J.E. (2005). Inhibitors of the mammalian target of rapamycin. Expert Opin. Investig. Drugs 14, 313-328. (Pubitemid 40520970)
4. XL mRNA expression in human hepatocellular carcinoma. Cancer Invest. 25, 226-231. (Pubitemid 47026944)
5. Faivre, S., Kroemer, G., and Raymond, E. (2006). Current development of mTOR inhibitors as anticancer agents. Nat. Rev. Drug Discov. 5, 671-688. (Pubitemid 44151605)
6. Franken, N.A., Rodermond, H.M., Stap, J., Haveman, J., and van Bree, C. (2006). Clongenic assay of cells in vitro. Nat. Protoc. 1, 2315-2319.
7. Gottesman, M.M. (2002). Mechanisms of cancer drug resistanace. Annu. Rev. Med. 53, 615-627.
8. Guertin, D.A., and Sabatini, D.M. (2005). An expanding role for mTOR in cancer. Trends Mol. Med. 11, 353-361. (Pubitemid 41080576)
9. Hamacher-Brady, A., Brady, N.R., and Gottlieb, R.A. (2006). Enhancing macroautophagy protects against ischemia/reperfusion injury in cardiac myocytes. J. Biol. Chem. 281, 29776-29787. (Pubitemid 44536987)
10. Hartford, C.M., and Ratain, M.J. (2007). Rapamycin: something old, something new, sometimes borrowed and now renewed. Clin. Pharmacol. Ther. 82, 381-388. (Pubitemid 47414349)
11. Kawamata, S., Sakaida, H., Hori, T., Maeda, M., and Uchiyama, T. (1998). The upregulation of p27Kip1 by rapamycin results in G1 arrest in exponentially growing T-cell lines. Blood 91, 561-569. (Pubitemid 28053379)
12. Kim, K.W., Hwang, M., Moretti, L., Jaboin, J.J., Cha, Y.I., and Lu, B. (2008). Autophagy upregulation by inhibitors of caspase-3 and mTOR enhances radiotherapy in a mouse model of lung cancer. Autophagy 4, 659-668.
13. King, M.A., Hands, S., Hafiz, F., Mizushima, N., Tolsovsky, A.M., and Wyttenbach, A. (2008). Rapamycin inhibits polyglutamine aggregation independently of autophagy by reducing protein synthesis. Mol. Pharmacol. 73, 1052-1063. (Pubitemid 351439187)
14. Komata, T., Kanzawa, T., Takeuchi, H., Germano, I.M., Schreiber, M., Kondo, Y., and Kondo, S. (2003). Antitumour effect of cyclin-dependent kinase inhibitors (p16(INK4A), p18(INK4C), p19(INK4D), p21(WAF1/CIP1) and p27(KIP1)) on malignant glioma cells. Br. J. Cancer 88, 1277-1280. (Pubitemid 36606346)
15. Koneri, K., Goi, T., and Hirono, Y. (2007). Beclin1 gene inhibits tumor growth in colon cancer cell lines. Anticancer Res. 27, 1453-1457. (Pubitemid 46807222)
16. Kuma, A., Hatano, M., Matsui, M., Yamamoto, A., Nakaya, H., Yoshimori, T., Ohsumi, Y., Tokuhisa, T., and Mizushima, N. (2004). The role of autophagy during the early neonatal starvation period. Nature 432, 1032-1036. (Pubitemid 40052234)
17. Lee, M., Ahn, J.-H., and Eum, K.-H. (2009). The differences in biological properties between parental and v-Ha-ras transformed NIH3T3 cells. Cancer Res. Treat. 41, 93-99.
18. Marinov, M., Fischer, B., and Arcaro, A. (2007). Targeting mTOR signaling in lung cancer. Crit. Rev. Oncol. Hematol. 63, 172-182. (Pubitemid 46990916)
19. Mashima, T., and Tsuruo, T. (2005). Defects of the apoptotic pathway as therapeutic target against cancer. Drug Resist. Updat. 8, 339-343. (Pubitemid 43358057)
20. Mazzanti, R., Platini, F., Bottini, C., Fantappie, O., Solazzo, M., and Tessitore, L. (2009). Down-regulation of the HGF/MET autocrine loop induced by celecoxib and mediated by P-gp in MDR-positive human hepatocellular carcinoma cell line. Biochem. Pharmacol. 78, 21-32.
21. Meric-Bernstam, F., and Gonzalez-Angulo, A.M. (2009). Targeting the mTOR signaling network for cancer therapy. J. Clin. Oncol. 27, 2278-2287.
22. Miracco, C., and Cosci, E. (2007). Protein and mRNA expression of autophagy gene Beclin1 in human brain tumours. Int. J. Oncol. 30, 429-436.
23. Moretti, L., Yang, E.S., Kim, K.W., and Lu, B. (2007). Autophagy signaling in cancer and its potential as novel target to improve anticancer therapy. Drug Resist. Updat. 10, 135-143. (Pubitemid 47454724)
24. Panwalkar, A., Verstovsek, S., and Giles, F.J. (2004). Mammalian target of rapamycin inhibition as therapy for hematologic malignancies. Cancer 100, 657-666. (Pubitemid 38176841)
25. Pawarode, A., Shukla, S., Minderman, H., Fricke, S.M., Pinder, E.M., O'Loughlin, K.L., Ambudkar, S.V., and Baer, M.R. (2007). Differential effects of the immunosuppressive agents cyclosporin A, tacrolimus and sirolimus on drug transport by multidrug resistance proteins. Cancer Chemother. Pharmacol. 60, 179-188. (Pubitemid 46742532)
26. Pop, I.V., Pop, L.M., Ghetie, M.A., and Vitetta, E.S. (2009). Targeting mammalian target of rapamycin to both downregulate and disable the P-glycoprotein pump in multidrug-resistant B-cell lymphoma cell lines. Leuk. Lymphoma 50, 1155-1162.
27. Sir, D., and Ou, J.H. (2010). Autophagy in viral replication and pathogenesis. Mol. Cells 29, 1-7.
28. Sun, Y., Liu, J.H., Jin, L., Lin, S.M., Yang, Y., Sui, Y.X., and Shi, H. (2010). Over-expression of the Beclin1 gene upregulates chemosensitivity to anti-cancer drugs by enhancing therapy-induced apoptosis in cervix squamous carcinoma CaSki cells. Cancer Lett. 294, 204-210.
29. Ullman, E., Fan, Y., Stawowczyk, M., Chen, H.M., Yue, Z., and Zong, W.X. (2008). Autophagy promotes necrosis in apoptosis-deficient cells in response to ER stress. Cell Death Differ. 15, 422-425.
30. Weppler, S.A., Krause, M., Zyromska, A., Lambin, P., Baumann, M., and Wouters, B.G. (2007). Response of U87 glioma xenografts treated with concurrent rapamycin and fractionated radiotherapy: possible role for thrombosis. Radiother. Oncol. 82, 96-104. (Pubitemid 46097131)
31. Wu, C.P., Calcagno, A.M., and Ambudkar, S.V. (2008). Reversal of ABC drug transporter-mediated multidrug resistance in cancer cells: evaluation of current strategies. Curr. Mol. Pharmacol. 1, 93-105.
32. Yousefi, S., Perozzo, R., Schmid, I., Ziemiecki, A., Schaffner, T., Scapozza, L., Brunner, T., and Simon, H.U. (2006). Calpainmediated cleavage of Arg5 switches autophagy to apoptosis. Nat. Cell Biol. 8, 1124-1132. (Pubitemid 44473608)
33. Yue, Z., Jin, S., Yang, C., Levine, A.J., and Heintz, N. (2003). Beclin 1, an autophagy gene essential for early embryonic development, is a haploinsufficient tumor suppressor. Proc. Natl. Acad. Sci. USA 100, 15077-15082. (Pubitemid 37518019)